Searchable abstracts of presentations at key conferences in endocrinology

ea0029p829 | Endocrine tumours and neoplasia | ICEECE2012

Enhanced antitumor efficacy of fructose conjugated-gefitinib on lung cancer cell lines in vitro and in vivo

Hui H. , Zhang S. , Ding W. , Li J. , Zhao X. , Zuo M. , Wang X. , Gu W. , Pandol S. , Go V.

Cancer cells have shown an overexpressed fructose transporter GLUT5 and preferential utilization of fructose as compared to glucose, implicating that a fructose-based analogue would be a useful target for diagnosis and treatment of cancer. We have successfully synthesized the fructose conjugated-gefitinib compounds {N-[4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-7-methoxy-quinazolin-6-yl]-4- [N-methyl-N-(1-deoxy-1-fructosyl)]aminobutanamide}, and examined its antitumor effic...

ea0011oc57 | ThyroidOC57 British Thyroid Association Award | ECE2006

Treatment of experimental hyperthyroid Graves’ disease with decoy TNF-family ligand receptors, suggests an essential role for BAFF in production of thyroid stimulating antibodies

Gilbert JA , Kalled SL , Moorhead J , Hess D , Rennert P , Li Z , Khan Z , Banga J-P

Introduction and Aims: Graves’ disease (GD) is mediated by thyroid stimulating antibodies (TSAbs) to the TSH receptor (TSHR). Treatments for GD have remained unchanged for more than 40 years with less than 50% of patients achieving long term remission with medical therapy. Experimental animal models have been described which facilitate understanding of disease mechanisms and permit studies of novel immunotherapeutic interventions. However studies aiming to perturb the Th1...

ea0007s3 | Society for Endocrinology Dale Medal Lecture | BES2004

Corticotropin releasing factor (CRF) family of ligands and their receptors

Vale W , Bale T , Li C , Reyes T , Perrin M , Jamieson P , Chen A , Brar B , Vaghan J , Rivier J

CRF mediates numerous complementary stress-related endocrine (HPA), autonomic and behavioral responses. CRF antagonists block many stress-induced responses in experimental animals. Furthermore, perturbations of the CRF system or HPA have been reported in human affective disorders. CRF acts through two Class B G protein coupled receptors derived from two genes, which have alternative splice variants and distinct expression patterns. Mice null for CRF-R1 exhibit reduced basal an...

ea0004p34 | Cytokines and growth factors | SFE2002

IGFBP-3 mRNA expression is reduced in normal colonic mucosa of colorectal patients with colorectal cancer compared to mucosa from non cancer patients

Ogunkolade B , Kelly|P## , S##Khalaf P , Fairclough P , Li R , Ahmed S , Hands R , Bustin S , Jenkins P

Background:Circulating levels of IGFBP-3 are inversely associated with the risk of developing colorectal cancers (CRC). In addition to modulating IGF bioavailability, IGFBP-3 also exerts independent pro-apoptotic effects. Furthermore, the mode of action of several apoptotic and antiproliferative agents, including vitamin D, has been shown to involve induction of IGFBP-3.Aims:To quantitate and compare IGFBP-3 ...

ea0056p863 | Pituitary - Clinical | ECE2018

Interim results of a non-interventional, observational study evaluating the long-term safety and efficacy of pasireotide sc in Cushing’s disease

Giordano Carla , Schopohl Jochen , Yuen Kevin C J , Kriemler-Krahn Ulrike , Li Jiang , Maamari Ricardo , Manetti Luca

Introduction: Subcutaneous (sc) pasireotide effectively reduces cortisol levels, improves signs/symptoms and is generally well tolerated in Cushing’s disease (CD) patients, as shown in previous clinical trials. We report interim results from a multicentre, real-world observational study evaluating the long-term safety and efficacy of pasireotide sc in clinical practice in CD patients.Methods: Adults with CD, for whom surgery has failed or is not an ...

ea0073oc7.6 | Oral Communications 7: Diabetes, Obesity, Metabolism and Nutrition | ECE2021

NTCP is a new promising target for treatment of metabolic diseases: A proof of mechanism from double-blind phase I clinical trials of Hepalatide

Zhu Zhenzhen , Tang Xiaolu , Zhu Shanwei , Wang Lizhen , Gao Xian , Cai Fei , Zhang Li , Liu Hongli , Wei Zhenman

Bile acids (BAs) are potent signaling molecules that regulate glucose, lipid and energy homeostasis predominantly via farnesoid X receptor (FXR) and transmembrane G protein-coupled receptor 5 (TGR5). Modulation of bile acid profiles might affect the treatment of metabolic diseases, indicating new possible therapeutic avenues. The sodium taurocholate co-transporting polypeptide (NTCP) plays a pivotal role in the enterohepatic circulation of bile salts as the main uptake transpo...

ea0098c45 | Clinical – Surgery/Applied Pathology | NANETS2023

Grade progression in gastrointestinal neuroendocrine tumors

Hill-Fung Lau Bryan , Moon Farhana , Joseph Nancy , Nakakura Eric , Khuong Le Bryan , Wang Stephanie , Zhang Li , Bergsland Emily

Background: Gastrointestinal neuroendocrine tumors (GI NETs) are subdivided into grades (G) G1-G3 based on Ki-67 proliferation index (%) (G1<3%, G2 3-20%, and G3 >20%) or mitotic rate, with tumor grade informing prognosis and treatment. Grade progression (GP) over time in GI and pancreatic NETs has recently been identified, with low(G1/2)-to-high(G3) grade progression (L-to-H) the most clinically relevant form. L-to-H is associated with worse survival, yet the timefram...

ea0098o4 | Other | NANETS2023

Baseline grade discordance in patients with pancreatic neuroendocrine tumors (PanNETs)

Moon Farhana , Wang Stephanie , Paciorek Alan , Khuong Le Bryan , Nakakura Eric , Zhang Li , Joseph Nancy M. , Bergsland Emily

Background: Pancreatic neuroendocrine tumors (panNETs) are heterogeneous, with grade (G) defined by Ki67 proliferation index (<3% G1, 3-20% G2, and >20% G3) or mitotic rate. Previous studies suggest that baseline Ki67 index may be confounded by biopsy site (primary or metastasis), biopsy technique and primary tumor size. Ki67 differences leading to grade discordance in PanNETs at baseline is relatively understudied. Our study aims to evaluate grade discordance in synch...

ea0077p243 | Reproductive Endocrinology | SFEBES2021

The effect of exogenous kisspeptin administration in a novel mouse model of hypothalamic amenorrhoea

Shrewsbury Jed V , Ng Kah-Yan , McIntyre Caitlin , Li Xiao Feng , Phylactou Maria , O’Byrne Kevin T , Abbara Ali , Dhillo Waljit S , Owen Bryn M

Kisspeptin is integral to hypothalamo-pituitary-gonadal (HPG) axis function and overall fertility. Functional deficiency of GnRH/lH secretion in the central reproductive disease, hypothalamic amenorrhoea (HA), indicates diminished kisspeptin signalling. Clinical trials have shown kisspeptin to be a viable therapeutic intervention. However, repeated administration led to the development of tachyphylaxis and so is likely a problem for future implementation. Indeed, elevated LH r...

ea0081rc2.1 | Rapid Communications 2: Adrenal and Cardiovascular Endocrinology 1 | ECE2022

A rapid genetic diagnosis for >80% individuals with non-CAH Primary Adrenal Insufficiency is achievable by candidate gene sequencing combined with WES

Smith Chris , Read Jordan , Hall Charlotte , Maharaj Avinaash , Marroquin Ramirez Lucia , Qamar Younus , Hughes Claire , Clark Adrian , Prasad Rathi , Chan Li , Musa Salwa , Metherell Louise

Primary adrenal insufficiency in children can be due to mutations in >20 genes, most commonly CYP21A2, giving rise to 21-hydroxylase deficiency. Phenotypically these disorders overlap and present with conditions ranging from isolated (or familial) glucocorticoid deficiency (FGD) to syndromic disorders involving multiple tissues. Distinguishing between them can be problematic, especially where biochemical testing is not possible or not undertaken. Over the last 30 ...